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Summary
In recent reportswe have described the generation of natural killer (NK) lines devoid ofCD3/TCR
structures but with apparent specificity for allogeneic target cells. Using one such NK line as
an immunogen, wenow report the generation of two monoclonal antibodies (mAbs), designated
2-13 and 5-38, which bind selectively to the majority ofCD3 - , CD16+, CD56+ lymphocytes
and inhibit the lysis of specific allogeneic target cells by a panel of alloreactive NK lines. By
contrast, these mAbs had no effect on classical NK cell mediated lysis of K562 cells o'major
histocompatability-restricted T cell-mediated cytolysis. Immunoprecipitation ofradiolabeled NK
lines followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis revealed that
the target molecules of both mAbs have a molecular mass of approximately 180 kD. Leu 19,
a well-described anti-CD56 mAb, precipitated a 180kD protein from NK cells, and the binding
of Leu 19 to NK cells was blocked by pretreatment with both 2-13 and 5-38 . However, in, contrast
to these mAbs, Leu 19 had no effect on the cytolytic activity of allospecific NK cells . Squential
immunoprecipitation analysis revealed that all three mAbs recognized distinct molecular species
ofCD56 . We interpret these findings as indicating that multiple isoforms ofCD56 are differentially,
expressed on NK lines and play critical roles in the recognition/interaction of these cells with
their specific allogeneic targets.
N
atural killer (NK) cells constitute up to 25% ofPBLs
in humans and can be distinguished from other lym-
phocytes on the basis of their ability to lyse selected tumor
lines and virus-infected cells without prior sensitization or
restriction by MHC class I or II gene products (1-3) . Al-
though a small subpopulation of CD3/TCRbearing lym-
phocytes have NK-like activity (4), classical NK cells lack
CD3/TCR structures and express cell surface markers such
as CD16 and CD56 (5-7) . Despite their distinct function
and phenotype, however, to date neither target structure(s)
(ligands) nor recognition molecules (receptors) ofNK cells
have been identified .
Recently, we and others have provided evidence for the
existence of CD3/TCR independent, alloantigen recogni-
tion byNK cells (8-10) . In such studies, NK lines and clones
were generated which not only killed classical NK-sensitive
targets such as K562 cells but, in addition, selectively lysed
the allogeneic cells (lymphocytes, lymphoblastoid cell lines
(LCL)t, or endothelial cells) with which fresh peripheral
blood derived NK cells had been cocultured . In the present
study we used one of these alloantigen-specific NK lines as
' Abbreviations used in thispaper . LCL, lymphoblastoid cell line ; N-CAM,
neural cell adhesion molecule.
animmunogen for the purpose of generatingmAbs that recog-
nize molecules on the surface ofNK cells involved in allo-
antigen-specific cytolysis. Two mAbs were generated that in-
hibit alloantigen-specific killing without affecting the lysis
ofK562 cells . These mAbs appear to recognize different iso-
forms ofCD56, suggesting that this molecule, which is selec-
tively expressed on lymphocytes with NK activity, plays a
critical role in alloantigen recognition/cytolysis ofNK cells .
Materials and Methods
Generation ofAntigen-speck CD3 -, CD56* Natural Killer Cell
Line. Procedures for generation of antigen-specificNK lines have
been described in detail (8). Briefly, highly purified CD3- , CD16+
cells were incubated on a monolayer of irradiated LCL (ARENT
line, HLA A2,2:B38,39:DR6,6 and MSAB line A1,2:B57,57:
DR7,7) which had been bound to flat-bottomed microtiter wells
with Cell-Tak (Biopolymers, Inc., Farmington, CT) . Thereafter,
cells adherent to theLCL were recovered and cultured in medium
supplemented with IIr2-containing supernatant. Culture medium
supplemented with this supernatant was added every 2-3 d, to-
gether with the original stimulator LCL. The resultingNK lines
express CD56 but not CD3, and lyse the original LCL with sub-
stantially greater potency than irrelevant LCL. NK sensitive K562
cells are lysed by all of the NK lines with high potency (8).
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6-wk-old female BALB/c
mice were immunized with an NK line (designated NS2) gener-
ated as described above. Immunizations were performed using Ribi
adjuvant (Ribi Immunochem Research, Inc., Hamilton, MT) ac-
cording to the manufacturer's protocol. After the thirdimmuniza-
tion, mice were splenectomized and splenocytes were fused with
SP2/0 myeloma cells as described (11) . Hybridoma supernatants
were screened on the basis oftheir ability to inhibit the allospecific
cytotoxic activity of the immunizing NK line, using "Cr-labeled
ARENT cells as targets in a 4-h "Cr-release assay (8). This
screening procedure led to the identification of two antibody
secreting hybridomas that inhibited the cytolytic activity of the
antigen-specific NK line against its original stimulator LCL,
ARENT These hybridomas were isolated and subcloned by lim-
iting dilution .
Immunofluorescence Analysis.
￿
AllmAbs used in this study were
produced and purified in this laboratory as described (12) with the
exception of Leu 19 (anti-CD56), which was kindly provided by
Dr . Lewis Lanier ofBecton-Dickinson Corp. (MountainView,CA).
Immunofluorescence staining was performed as described (8, 12).
In brief, determination ofthe distribution of the surface molecule(s)
recognized by thesemAbs utilized two-color analysis in which cells
were stained withmAbs 2-13 or 5-38, followed byFITC-conjugated
rat anti-mouse IgG2aAb (Zymed Laboratory, San Francisco, CA)
andoneofthe following reagents: anti-Leu-2, anti-Leu 3, anti-Leu
4, or anti-Leu 11 mAb directly conjugated to PE . To determine
whethermAbs 2-13 and/or 5-38 block the binding ofothermAbs,
PBL were treated with 2-13 or 5-38 mAbs at 4° C for 30 min,
washed andthen stained with fluorochrome-conjugatedmAband
analyzed in a flow rytometer (12) . To study the nature of the epi-
topes recognized by these mAbs, PBLs were treated with various
concentrations of neuraminidase or trypsin (Sigma ChemicalCo.,
St . Louis, MO) at 37°Cfor30 min, or were cultured with 1-10
14g/ml tunicamycin (Calbiochem-Behring Corp., San Diego, CA)
for 1-3 d . Thereafter, the cells were analyzed by indirect im-
munofluorescence with mAbs 2-13 and 5-38 as well as mAbs to
HLA-DR and Leu 7 (CD57) .
Analysis ofImmunoprecipitates.
￿
NK lines and KGla5 leukemic
cells (kindly provided by Dr. Lewis Lanier of Becton-Dickinson
Corp.) (13) were washed five times in cold PBS, and surface-labeled
with "iodine using the lactoperoxidase method or, alternatively,
metabolically labeled with ['IS]methionine as described elsewhere
(14) . After radiolabeling, cells were washed three times with PBS
and suspended in lysis buffer containing 1% NP-40. The lysates
were pre-cleared three timeswith packed ProteinASepharosebeads
for 2 h under rotation, followed by incubation with hybridoma
supernatant for 2 h at 4°C . 20 pl of packed Protein ASepharose
beads was then added, and samples were incubated overnight at
4°Cunder rotation. Immunoprecipitates were eluted from Protein
A-Sepharose by boiling for 5 min in buffer containing 1% SDS
in the presence or absence of 5% 2-ME and analyzed on SDS-
polyacrylamide gels (11, 14) . Peptide mapping was performed as
described (15), using protease XVII from Staphylococcus aureus strain
VS (Sigma Chemical Co.) (15) .
Cytotoxicity Assays.
￿
The alloantigen-specific NK cell line and
fresh NK-enriched PBL (obtained by Percoll centrifugation)were
tested as effectors in 4-h "Cr-release cytotoxicity assays as de-
scribed (8). CD4` and CD8* allospecific cytotoxic T cell lines,
generated as described (16) were also used as effectors . In experi-
ments designed to explore the role of cell surface molecules in
cytotoxicity, mAbs were added at the initiation of the 4-h "Cr-
release assays. In hybridoma lysis assays (17), mAb producing hy-
bridomas were labeled with "Cr and used as targets in 4-h "Cr-
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release assays . All hybridomas expressed surface immunoglobulin
as determined by immunofluorescence analysis on a flow rytometer .
Results
Mice were immunized as described in Materials and
Methods with an allospecific NK cell line designated NS2
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￿
Cytotoxic activity ofCD3 - NK cell lines which were used
in this study . The lines were generated as described in Materials andMethods
and tested for cytotoxic activity against the original stimulator LCL, ir-
relevant LCL (PGF, HLA A3, -:B7, -:DR2,-), and K562 cells, using a
4-h s1Cr-release assay. Values represent the mean percent killing of tripli-
cate wells.X
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￿
Effects of2-13 and 5-38 mAbs on alloantigen specific cyto-
toxic activity. The ARENT specific NK line, NS2 (CD3 - , CD56*),
which had been used as the immunogen was tested for cytolytic activity
against theARENT line at an EIT of 10:1 in the presence or absence
of 50% vol of hybridoma supernatant which was added to the wells at
the onset of 4-h s1Cr-release assays . 2-12mAb which does not affect any
knownimmune responses (data not shown) is included as a negative control .
(surface phenotype CD3 - , CD56+) derived from peripheral
blood CD3- , CD16+ lymphocytes . Similar to lines previ-
ously generated in this laboratory (8), NS2 displayed preferen-
tial cytolytic activity against its original stimulator LCL
(ARENT) as well as NK-sensitive (K562) target cells (Fig .
1) . The supernatants of two hybridomas were identified on
the basis of their ability to selectively inhibit the lysis of
ARENT cells by the NS2 line (Fig . 2), and these hybrid-
omas were cloned by limiting dilution and themAbs (desig-
nated 2-13 and 5-38) were studied further.
Immunofluorescence analysis of PBL obtained from 10
different subjects revealed that 10-25% of cells were reactive
with these mAbs (Fig. 3 A) . To compare the expression of
the target molecules ofmAbs 2-13 and 5-38 with that of
other lymphocyte surface markers, two-colorimmunofluores-
cence analysis was performed in whichPBL were stained with
both an anti-CD16 mAb (Leu 11) and either 2-13 or 5-38 .
The results (Fig . 3 B) indicate that the majority ofcells reac-
tive with 2-13 or 5-38 are also reactive with anti-CD16mAb.
It should be stressed, however, that some CD16+ cells were
2-13 and 5-38 negative, and a small proportion ofCD3'
cells were 2-13 and 5-38 positive. Although no 2-13 and
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5-38 positive cells coexpressing CD4 would be detected, a
subset of 2-13 and 5-38 positive cells consistently expressed
the CD8 antigen . Most importantly, Leu 19, a well-charac-
terized anti-CD56 mAb, stained substantially the samePBL
as that stained by 2-13 and 5-38 (not shown), and pretreat-
ment ofPBL with either 2-13 or 5-38 abolished the reac-
tivity of PE-conjugated Leu 19 (anti-CD56) antibody (Fig.
3 A), but not of other mAbs tested, including .antibodies
to CD2, CD3 (OKT3), CD16, CD45RA, CD45RO, and
Leu 7 (Fig. 3 A, and data not shown) . This suggests that
the molecules recognized by 2-13 and 5-38 are identical or
closely associated with theCD56 antigen on the cell surface.
Like Leu 19, the 2-13 and 5-38 mAbs did not react with
normal B cells, monocytes or granulocytes, and did not bind
lymphoblastoid cell lines, including theARENT line which
was the specific stimulus ofthe NS2 NK line. Among a panel
oftumor cell lines analyzed, only theKG1 leukemic line(20%
+) and a subclone of that line, designated KG1a5 (90% +)
were recognized by 2-13 and 5-38. Leu 19 also stained the
KG1a5 clone but failed to stain the parental KG1 cells, indi-
cating that the 2-13 and 5-38 mAbs recognize either a dis-
tinct epitope onCD56 or a distinct protein from that recog-
nized by Leu 19 . Moreover, when antigen-specific NK lines
of different target specificity were stained with thesemAbs
(Fig. 4), the staining patterns of 5-38 are clearly distinct from
that ofLeu 19 or2-13. For example, anNK line with specificity
for theARENT lymphoblastoid cell line (Fig. 4, line B) ex-
hibits uniformly bright staining with 5-38, but both dull
and bright populations when stained with 2-13 or Leu 19 .
In addition, the staining pattern of these mAb on different
NK lines also varies, indicating that the expression of the
epitopes recognized by these antibodies varies among NK
lines . Thus, for example, while the 5-38 antibody stains an
anti-ARENT NK line with high, uniform density (Fig. 4,
line B), the same antibody exhibits variable staining on the
MSAB-specific NK line (Fig. 4, line A) . When combined
with the results presented earlier, these findings suggest that
there are differences between the epitopes recognized by 2-13,
5-38, and Leu 19.
To explore the possibility that the molecules recognized
by these mAbs may have a physiologic role in activating or
upregulatingNK activity, we took advantage ofa hybridoma
lysis assay, a relatively simple and direct system in which an-
tibody secreting hybridoma cells are "Cr-labeled and then
cultured with cytotoxic effectors to determine their suscepti-
bility to lysis (17) . As shown in Fig. 5, both the 2-13 and
5-38 antibody secreting hybridomas were lysed by freshPBL .
Hybridomas secreting antibodies that recognize other mole-
cules expressed byNK cells were studied as controls. An anti-
CD16 secreting hybridoma was similarly lysed by fresh PBL,
whereas an anti-CD11b expressing hybridoma was resistant
to lysis . Identical results were obtained when fresh CD16+
NK cells, enriched from peripheral blood by Percoll gradient
centrifugation, were used as effectors (data not shown) . These
results suggest that the structure(s) recognized by the 2-13
and 5-38 mAbs play a direct role in the cytolytic activity
of NK cells.
Despite these findings, however, neither ofthesemAbs hadA
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Immunofluorescence analysis of cell surface antigens recognized by 2-13 and 5-38 mAbs. (A) The top row depicts normal PBL which
were stained with PE-Leu 19 mAb, 2-13 or 5-38 mAbfollowed by FITC-rat anti-mouse IgG2a antibody. Thebottom row depicts antibody blocking
of PBL pretreated with 2-13, 5-38, or OKT3 mAb at 4°C for30 min, washed and stained with PE-Leu 19 mAb. (B) PBL were treated with 2-13
or 5-38 mAb followed by FITC-rat anti-mouse ,IgG2a antibody, and further stained with PE-conjugated anti-CD16, CD4, CD8, or CD3 mAbs.
Stained cells were analyzed in a flow cytometer as described in Materials and Methods.B
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any effect on the lysis of K562 cells by the NS2 NK line or
fresh PBL (Fig. 6, A and B) . In addition, these mAbs had
no inhibitory effect on class IMHC restricted cytolysis medi-
ated by CD8+ T cells or class II MHC restricted cytolysis
mediated by CD4+ T cells, even when the ARENT cell line
was used as the stimulator and target of such cytolysis (Fig .
6, C and D) . These results are not surprising since neither
the T effector cells nor the target ARENT cells are stained
by mAbs 2-13 or 5-38 .
We next analyzed the effects of these and other mAbs on
the cytotoxicity of three additional antigen-specific NK lines
(Fig. 7A) . Two ofthese lines, like theNS2 line, were gener-
ated against ARENT cells, while a third NK line was gener-
ated against an unrelated lymphoblastoid line, MSAB. As
shown, the antigen-specific cytotoxicity o£all threeNK lines
cytotoxicity
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￿
- 1
￿
1 i
Figure 5.
￿
Lysis of hybridomas by PBL . PBL were assayed for cytotox-
icity against S 1Cr-labeled hybridoma cell line in a 4-h radioisotope release
assay . E/T - 10 :1 .
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Immunofluorescence analysis of 2-13 and 5-38 antigens on alloantigen-specificNK lines . Two NK lines with different target specificities
([A] specific forMSAB ; [B] specific forARENT) were separated from feeder cells over a Ficoll-Hypaque gradient and surface antigen expression was anal
was completely inhibited by a mAb to LFA1-cx, whereas Leu
19 and Leu 7 mAbs had no effect on cytolysis. mAbs 2-13
and 5-38 inhibited the cytotoxicity ofall threeNK lines against
their specific targets, albeit to a lesser extent than the anti-
LFA1 mAb. As shown in Fig. 7 B, these mAbs inhibited
allospecific cytotoxicity in a concentration-dependent manner.
In combination with our earlier results, which indicate that
both 2-13 and 5-38 mAbs bind to the majority ofperipheral
blood NK cells, these findings are interpreted as suggesting
that both mAbs recognize a framework determinant on a
molecule or molecules involved in allospecific interactions be-
tween NK cells and their targets .
To explore the structural characteristics of the surface an-
tigens) recognized by 2-13 and 5-38, the antigen-specific
NK line, NS2, and KG1a5 leukemic cell line were surface-
labeled with
1251 or metabolically labeled with 35S-methi-
onine, followed by immunoprecipitation with 2-13, 5-38,
or Leu 19, and analysis ofthe precipitates bySDS-PAGE. These
mAbs precipitated an approximately 180-kD protein from
the NS21ine as well as the KG1a5 clone under reducing and
nonreducing conditions (Fig . 8), similar to that previously
reported for Leu 19 (5, 7, 13) . However, the Leu 19 precipi-
tate migrates as a broader band (160-185 kD) than the 2-13
or 5-38 precipitates (170-180 kD) . To further analyze the
molecules recognized by 2-13, 5-38, and Leu 19 mAbs, se-
quential immunoprecipitation was performed on a radiola-
beled lysate ofKG1a5 cells in which the lysate was twice im-
munoprecipitated with one of the mAbs (until no further
band at 180 kD was visible by SDS-PAGE), followed by im-
munoprecipitation with another of the mAbs . As shown in
Fig . 9, the Leu 19 pre-cleared lysate yielded similar but some-
what smaller proteins when immunoprecipitated with either
5-38 or 2-13 . Analogous results were obtained in lysates
precleared with either 5-38 or Leu 19, followed byimmuno-
precipitation with the reciprocal antibodies . These results
clearly indicate that the target molecule(s), presumably iso-
forms ofCD56, are heterogeneous, and that while some of2-12
lcontrol mAb)
Figure 6.
￿
Effects of 2-13 and 5-38 mAb on various cytotoxic effector populations. An alloantigen-specific NK line (A) and PBL (B) were assayed
for cytotoxicity against 5'Cr-labeled K562 cells in a 4-h 51Cr-release assay performed in the presence of 50% volume of hybridoma supernatant. E/T
- 20:1 for A and 50 :1 for B . CD4+ (C) and CD8+ (D) CTL lines specific for ARENT, the same stimulator used to generate the NS2 NK cell
line, were assayed for cytotoxicity againstARENT cells in a 4-h 51Cr-release assay performed in the presence of 50% volume of hybridoma superna-
tant . E/T = 20:1 for both C and D .
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Figure 7 . Effects of 2-13 and
5-38 mAbs on the allospecific cyto-
lytic activity ofa panel ofNK lines .
(A) Antigen-specificNK lineswith
two different target specificities were
assayed for their cytotoxic activity
against their original stimulator
LCL in 4-h 51Cr-release assays in
the presence of various mAbs; for
these assays 2-13 and 5-38 mAbs
werepresent as 50% volume ofcul-
ture supernatant, while the final
concentration of LEA-1a, Leu 19,
and Leu 7 mAbs was 25 wg/ml .
(B) An ARENTspecific NK line
(NK8171) was assayed for cytolytic
activity against its original stimu-
lator LCL in the presence of varying
amounts of 2-13 or 5-38mAb cul-
turesupernatants . E/T ratio - 20:1 .these forms are recognized by all three mAbs, other forms
are not .
To further characterize the target molecules of thesemAbs,
the radiolabeled immunoprecipitates were subjected to diges-
tion with V8 protease, and the cleaved products analyzed by
SDS-PAGE . As shown in Fig . 10 A, theV8 cleaved products
of the three immunoprecipitates are similar. However, under
the milder conditions of Fig. 10 B, 50-kD and 47-kD bands
were visible in the 5-38 digest (indicated by arrows), whereas
in the Leu 19 digest only the 50-kD band can be seen (indi-
cated by an arrow) . The 47-kD band was reproducibly present
in 5-38 digests but not in Leu 19 digests, strongly suggesting
that there are minor amino acid sequence differences between
some of the CD56 proteins recognized by the three mAbs
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Figure 8.
￿
SDS-PAGE analysis of
surface molecules immunoprecipi-
tated by 2-13 and 5-38 mAbs. The
KG1a5 leukemic cell line (A) and
an alloantigen specificNK line (B)
were surface labeled with 1251 using
the lactoperoxidase technique, and
lysed in buffer containing 1% NP-
40 . Immunoprecipitation was per-
formed with 2-13 mAb and 5-38
mAb coupledtoproteinAsepharose
beads. SDS-PAGE analysis was per-
formed under reducing and non-
reducing conditions, using 8%
acrylamide gels for the KG1a5 ly-
sate and6% acrylamide gels for the
NK lysate. The Leu 19 immunopre-
cipitate was included as a control .
(C) representsimmunoprecipitation
with nonimmune mouse serum.
under study. When combined with the earlier analysis of se-
quential immunoprecipitates (Fig . 9), it is apparent that these
mAbs recognize several proteins, some of which share epi-
topes and some of which do not .
In a final series of experiments designed to determine
whether the epitopes recognized by 2-13 and 5-38 contain
carbohydrate, PBLs were treated with neuraminidase to re-
move sialic acid or cultured with tunicamycin to prevent in-
corporation ofN-linked carbohydrate (13, 18,19) . Thebinding
of 2-13 and 5-38, as well as Leu 19, to NK cells was not
reduced by either procedure, whereas the binding of anti-
HLA-DR antibody included as a positive control, was
significantly reduced as previously reported (19) (data not
shown) . By contrast, treatment of NK cells with trypsin
Figure 9.
￿
Sequentialimmunopre-
cipitation of 2-13, 5-38, and Leu
19 from KG1a5 cells. KG1a5 cells
were labeled with 35S-methionine
and detergent solubilized . The ly-
sates were substantially depleted of
2-13 antigen, 5-38 antigen, andLeu
19 antigen by immunoprecipitation
with 2-13, 5-38, and Leu 19 mAbs,
respectively. Each precleared lysate
was once more immunoprecipitated
with the same mAb and complete
depletion oftherelevant antigenwas
confirmed by SDS-PAGE. After
depletion, the lysates wereimmuno-
precipitated with the other mAbs.
Immunoprecipitates were analyzed
by 5% SDS-PAGE gel under re-
ducing conditions.resulted in nearly complete loss of the binding of 2-13, 5-38,
and Leu 19 to NK cells while only slightly affecting the ex-
pression of Leu 7 (CD57), a glycolipid antigen (data not
shown) . These results confirm that the epitope recognized
by 2-13 and 5-38 are amino acid rather than carbohydrate
in nature .
Figure 10 .
￿
V8 protease digestion of 2-13, 5-38, and Len 19 antigens from KG1a5 cells . 35S-methionine
labeled KG125 cells were detergent solubilized, precipitated with mAbs 2-13, 5-38, and Leu 19 and sepa-
rated by SDS-PAGE as in Fig . 9 . (A) The major bands were cut from the gels and digested with 0, 100,
and 750 ng of Staphylococcus aureus VS protease, and analyzed by SDS-PAGE (reducing conditions) using
a 15% acrylamide gel. (B) 5-38 and Leu 19 proteins recovered as above were digested with 75 ng of V8
protease. (Arrows) indicate differences between these two digests .
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Discussion
NK cells are defined as lymphocytes that lyse selected tumor
cells or virally infected cells without prior sensitization or
MHC gene restriction (1-3) . Despite the fact that NK cells
have a limited target cell range, no specific NK-associated sur-
face receptor or target ligand has yet been defined, leading
to speculation that such effectors lack a highly refined an-
tigen recognition system . However, previous attempts to ab-
sorb NK activity with target cells suggested heterogeneity
of both NK recognition and target structures (20, 21) . In
addition, NK cells have been shown to mediate hybrid resis-
tance to parental bone marrow allografts (22, 23), a phe-
nomenon that appears genetically restricted and directed at
the products of noncodominant hematopoietic histocompati-
bility genes (24) . Recently, we and others have provided evi-
dence for alloantigen recognition by CD3- NK cells (8-10),
and on the basis of these observations it would appear that
at least some NK cells have the ability to distinguish target
cells from one another.
In the present study, using an alloantigen-specific NK line
as an immunogen, we generated two mAbs which inhibit
alloantigen-specific cytotoxic activity of CD3 - NK cells
without affecting the ability of these cells to kill classical NK
targets such as K562 cells . Immunofluorescence analysis of
PBL, KG1 cells, and NK lines recognizing different targets
revealed that the antigenic epitopes recognized by these two
Natural Killer Cell FunctionFigure 11 .
￿
Proposed representation of CD56 isoforms.
mAbs are closely associated with, but not identical to the
target molecule ofLeu 19, a well-described anti-CD56 mAb.
Thus, 2-13 and 5-38 block the staining of NK cells by
fluorochrome-conjugated Leu 19 mAb; however, the staining
patterns of Leu 19 on NK cells differs from that of 5-38,
and Leu 19 had no effect on the lysis of allospecific target
cells by NK lines, in contrast to 2-13 and 5-38 . Sequential
immunoprecipitation with these two mAbs and Leu 19, as
well as analysis of the peptides resulting from VS protease
digestion revealed that each mAb recognizes overlapping and
nonoverlapping isoforms ofCD56, a molecule expressed selec-
tively on lymphocytes with NK activity (5, 7) . Fig. 11 sum-
marizes in schematic form our interpretation of the current
results . Since the isoforms ofCD56 which lack one or more
epitopes are always smaller than those which have the epi-
tope (Fig . 9), and peptide mapping with V8 protease showed
minor difference of these isoforms, we favor the view that
different isoforms are generated by a combination of alterna-
tive splicing and posttranslational modifications rather than
posttranslational modification alone. In addition, the epitopes
recognized by 2-13 and 5-38 consist of amino acids (pro-
tein) rather than carbohydrate alone, since treatment ofPBLs
with neuraminidase or culture with tunicamycin did not re-
duce the binding of 2-13 and 5-38, whereas trypsin treat-
ment ofNK cells greatly reduced 2-13 and 5-38 antigen ex-
pression . Although it is not yet known how many isoforms
ofCD56 are present on NK cells, sequential immunoprecip-
itation confirmed the presence of at least four distinct iso-
forms. It is theoretically possible, and in our view likely, that
more than four different isoforms exist on NK cells .
The finding of multiple CD56 isoforms on NK cells is
consistent with the hypothesis that these isoforms constitute
an allorecognition apparatus with limited heterogeneity. This
view is also supported by the observation that although Leu
19, 2-13, and 5-38 mAbs stain most peripheral blood NK
cells, the staining pattern for each allospecific NK line is dis-
tinct (Fig. 3A) . An alternative explanation for our findings
is that CD56 plays an accessory role as a mediator ofnonspecific
adhesion between allospecific NK effectors and their targets .
However, it is difficult to reconcile this view with the exis-
tence of multiple CD56 isoforms on NK cells, the variable
expression ofthese isoforms on allospecificNK lines, and the
failure of any of our anti-CD56 mAbs to affect the lysis by
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NK cells of "nonspecific" targets such as K562 erythroleukemia
cells . Definitive evidence for either of these hypotheses will
require studies of cells transfected with cDNA's for the rele-
vant CD56 isoforms.
Since the hybridomas secreting 2-13 and 5-38 antibodies
are efficiently lysed by peripheralNK cells, it is apparent that
the CD56 isoforms play an important role not only in the
interaction between NK effectors and their targets but also
in the transduction of intracellular activation signals. Like
CD56, the molecules CD2, CD16, and the recently described
GL183 antigen have been shown to mediate signal transduc-
tion in NK cells (17, 25-27) . TheGL183 molecule is of par-
ticular interest since it was initially identified on some but
not all NK clones (27) ; however, this molecule, like CD2
and CD16, is invariant in structure and, therefore, unlikely
to be involved in alloantigen-specific interactions. The meta-
bolic pathway affected by 2-13 and 5-38 mAbs (and, by in-
ference, the natural ligands ofCD56 on NK target cells) re-
main to be studied . Nonetheless, our results suggest that the
rather confined expression ofCD56 on NK cells and T cells
with NK-like activity reflects a critical role for this molecule
not only in the interaction of NK cells with their targets
but also in the cytotoxic effector functions of NK cells.
Previous studies have suggested that CD56 is a single iso-
form ofthe neural adhesion molecule (N-CAM) (13), which
is expressed on neural and muscle tissues as multiple isoforms
and mediates homotypic adhesive interactions (28, 29) . In
chicken neural tissue, where N-CAM was initially identified
(28, 30) numerous isoforms are generated from a single gene
by differentialRNA splicing and posttranslational modifica-
tions, including the addition of Winked carbohydrates in
polysialic acid (28, 30) . Recently, N-CAM cDNA isolated
from human muscle tissue has been cloned and sequenced
(29) . HumanN-CAM has an immunoglobulin-like domain,
suggesting that it may function as a receptor for ligands yet
to be identified . In addition, Streuli et al . (31) have recently
isolatedcDNA encoding a cell surface molecule of undefined
function, termed LAR, which has an extracellular region ho-
mologous to both the Ig-like and non-Ig-like domain of
N-CAM . Thus, it is possible that 2-13 and/or 5-38 cross-
react with N-CAM andN-CAM-like molecules such asLAR.
In normal lymphoid tissues, CD56 is expressed predominantly
on NK cells and a subset of T cells with NK-like activity
(5, 7) . Although this preferential distribution and the im-
munoglobulin-like structure o£CD56 are consistent with an
important role for this molecule in NK cell function, before
the current studies, there has appeared virtually no evidence
to support this view although CD56 is reported to be in-
volved in cytotoxic activity and homotypic adhesion between
NK cells and CD56+ malignant neural cells (32) . On the
other hand, our results indicate that theCD56 isoforms rec-
ognized by 2-13 and 5-38 are directly involved in NK cell/
target cell interactions, and since theLCL targets studied here
lack any detectable expression ofCD56, it is clear that the
CD56 isoforms on NK cells mediate a heterotypic rather than
homotypic interaction between NK cells and their targets .
Although our limited peptide mapping analysis indicates that
there are amino acid sequence differences between theCD56isoforms on lymphoid cells, the relative contribution ofthese
differences versus posttranslational modifications to the dif-
ferential target cell recognition by distinct NK lines is un-
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known. Similarly, the nature of the natural ligand of these
isoforms on NK targets remains to be elucidated .
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